Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • MCP
  • API + Credits


logo
52 North Health logo

52 North Health

Recent Financing

Equity

Recent Raise

$4.2M

52North Health is a University of Cambridge spin-out developing the Aster™ biomarker detection platform and Neutrocheck®, a rapid finger-prick blood test for triaging chemotherapy patients at risk of neutropenic sepsis.

Founded 2018
Cambridgeshire, United Kingdom
11-50
Private
52north.health
PitchBook

Highlights

Focus Areas

Artificial Intelligence (AI)
Health Care
Medical

Recent Investors

Meridian Health Ventures (KHP Ventures) logo
Cancer Research Horizons logo
OKG Capital logo
Macmillan Cancer Support logo
Cambridge Enterprise logo
Innovate UK logo
Cedars-Sinai Intellectual Property logo
C
Hargreave Hale AIM VCT logo
University of Cambridge logo
Crista Galli Ventures logo
Milltrust Ventures logo

Financials

$13.4M

Total Raised

5

Funding rounds

11

Investors


Team

Upgrade to view the team

See the team members at 52 North Health.